Jean-Ehrland Ricci

14PUBLICATIONS

28CO-AUTHORS

Molecular targetsPredictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 02, 2026

The mannosyltransferase DPM1 regulates the activity of ER-stress sensor IRE1 in colorectal cancer.

|Feb 27, 2026

Tumor metabolic adaptation induced by L-asparaginase reveals a vulnerability to PARP1/2 inhibitor in B-cell lymphomas.

Anaïs Aussel, Ivan Nemazanyy, Ashaina Vandenberghe

|Jun 19, 2024

Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma.

Adrien Krug, Rana Mhaidly, Marie Tosolini

|Jun 13, 2024

Immunometabolism unveiled: Pioneering breakthroughs in cancer therapeutics.

Eric Eldering, Jean-Ehrland Ricci

|Feb 07, 2023

IL-7 germline variant: setting the stage for immune-related adverse events.

Hussein Issaoui, Jean-Ehrland Ricci

|Jul 20, 2022

Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression.

Manuel Grima-Reyes, Ashaina Vandenberghe, Ivan Nemazanyy

Pageof 3

Frequent Collaborators

Sandrine Marchetti

Johanna Chiche

Eric Chevet

Els Verhoeyen

Ivan Nemazanyy

Franziska Püschel

Francesca Favaro

Julie Pannequin

Blanca Majem

Ernest Nadal

Frequent Collaborators

Sandrine Marchetti

Johanna Chiche

Eric Chevet

Els Verhoeyen